STOCK TITAN

ReGen III Announces Settlement of Debenture Interest with Shares, Sale of Non-Core Asset, and Patents Update

(Neutral)
(Very Positive)
Tags
ReGen III Corp (ISRJF), a clean technology company focused on upcycling used motor oil, has announced several key updates. The company will settle its semi-annual debenture interest payment of $164,850 by issuing approximately 855,598 common shares at $0.19267 per share, subject to TSX Venture Exchange approval. Additionally, ReGen III has sold a non-core rural property in Slocan, British Columbia for $295,000. On the intellectual property front, the company secured its first Brazilian patent and was granted a European patent (EP3921390) by the European Patent Office. ReGen III now holds 22 issued, granted, or allowed patents for its ReGen process, with 11 patents pending globally.
Loading...
Loading translation...

Positive

  • Sale of non-core Slocan Property generated $295,000 in proceeds
  • Expansion of patent portfolio with new Brazilian and European patents
  • Strong intellectual property position with 22 patents issued/granted and 11 pending globally

Negative

  • Dilution of shareholder value through issuance of 855,598 new shares for interest payment

News Market Reaction – ISRJF

-26.03%
-26.03% Session move

In the trading session that priced this news, ISRJF declined 26.03%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ("ReGen III" or the "Company"), a leading clean technology company specializing in the upcycling of used motor oil ("UMO") into high-value Group III base oils, announces it has elected, pursuant to the terms of its Series 2023-11.PP55CD-A Debentures to pay the semi-annual interest payment due in the amount of $164,850 through the issuance of approximately 855,598 common shares at a price of $0.19267 per common share. Completion of the transaction remains subject to the approval of the TSX Venture Exchange. The securities issued are subject to a hold period of four months from the date of issue.

Land Sale

The Company is pleased to share that it has completed the sale of a rural property near Slocan, British Columbia (the "Slocan Property"), for gross proceeds of $295,000. The Slocan Property is a legacy, non-core Company asset that was secured during the business combination of Silver Ridge Resources and NMC Mining Corp. in 2010, prior to the Company's subsequent name changes and change of business in 2017.

Patents Update

ReGen III is also pleased to announce its Brazilian patent application (1120210154531) has been granted, with the corresponding Letters Patent to be issued by the Brazilian National Institute of Industrial Property in due course. This represents the Company's first patent granted in Brazil, a country which bans all burning of UMO and has the second highest rate of re-refining globally (Source: U.S. Department of Energy).

The Company also announces that its European patent application (20751968.7) was granted by the European Patent Office (the "EPO") on April 2, 2025, under patent number EP3921390. The EPO is the executive arm of the European Patent Organisation, an international organisation with 39 member states. The Company is now finalizing its selection from the list of member states and will advance into the national validation stage before July 2, 2025.

Following these determinations, ReGen III has twenty (22) patents issued, granted, or allowed for the Company's ReGen™ process and eleven (11) patents pending globally.

About ReGen III

ReGen III is a cleantech company commercializing its patented ReGen™ technology to upcycle UMO into high-value Group III base oils. With a focus on creating sustainable solutions that generate better environmental outcomes and compelling economics, the Company's ReGen™ process is expected to reduce CO2e emissions by 82% as compared to virgin crude derived base oils combusted at end of life.

ReGen III has completed FEL2 and value engineering for the Company's 5,600 bpd UMO Texas recycling facility, with the support of world-class engineering, construction and licensed vendor teams - including Koch Project Solutions, LLC, PCL Industrial Management Ltd., Studi Tecnologie Progetti S.p.A., Koch Modular Process Systems and Duke Technologies.

Operating in an underserved segment of the base oils market, ReGen III aims to become the world's largest producer of sustainable re-refined Group III base oil.

For more information on ReGen III or to subscribe to the Company's mailing list, please visit: www.regeniii.com/investors/corporate-presentations and www.regeniii.com/newsletter-subscription.

For further information, please contact:

Investor & Media inquiries:
Email: investors@regeniii.com

Corporate Inquiries:
Kimberly Hedlin
Vice President, Corporate Finance
Tel: (403) 921-9012
Email: info@regeniii.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain information other than statements of historical facts contained in this news release constitutes "forward-looking information" or "forward-looking statements" (collectively, "forward-looking information"). Without limiting the foregoing, such forward-looking information includes statements regarding the Company's business plans, expectations, capital costs and objectives. In this news release, words such as "may", "would", "could", "will", "likely", "believe", "expect", "anticipate", "intend", "plan", "estimate" and similar words and the negative form thereof are used to identify forward-looking information. Forward looking information should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. Forward-looking information is based on information available at the time and/or the Company management's good faith belief with respect to future events and is subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond the Company's control. For additional information with respect to these and other factors and assumptions underlying the forward-looking information made in this news release, see the Company's most recent Management's Discussion and Analysis and financial statements and other documents filed by the Company with the Canadian securities commissions and the discussion of risk factors set out therein. Such documents are available at www.sedarplus.ca under the Company's profile and on the Company's website, www.ReGenIII.com. The forward-looking information set forth herein reflects the Company's expectations as at the date of this news release and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/254104

FAQ

What is the value of ReGen III's debenture interest payment being settled in shares?

ReGen III is settling a debenture interest payment of $164,850 through the issuance of approximately 855,598 common shares at $0.19267 per share.

How much did ReGen III receive from the sale of its Slocan Property?

ReGen III sold its non-core rural property in Slocan, British Columbia for gross proceeds of $295,000.

How many patents does ReGen III currently have for its ReGen process?

ReGen III has 22 patents issued, granted, or allowed for its ReGen process, with an additional 11 patents pending globally.

What new patents did ReGen III receive in 2025?

ReGen III received its first Brazilian patent (1120210154531) and a European patent (EP3921390) granted by the European Patent Office.

What is the share price for ReGen III's interest payment settlement?

The shares for the interest payment settlement are being issued at a price of $0.19267 per common share.